OLANZAPINE AND FLUOXETINE

OLANZAPINE AND FLUOXETINE was reported 26 times

OLANZAPINE AND FLUOXETINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
1 LAZINESS 1 0.0006
2 DENTAL CARE 1 0.0005
3 DYSPHORIA 1 0.0002
4 INTERMENSTRUAL BLEEDING 1 0.0002
5 DECREASED INTEREST 1 0.0002
6 AUTOIMMUNE HEPATITIS 1 0.0001
7 IMMUNOSUPPRESSION 1 0.0001
8 AFFECT LABILITY 1 0.0001
9 SLUGGISHNESS 1 0.0001
10 SINUS TACHYCARDIA 1 0.0001
11 HYPOXIA 2 0.0001
12 DRUG ERUPTION 1 0.0001
13 PANCREATITIS ACUTE 1 0.0000
14 COMPLETED SUICIDE 3 0.0000
15 RESPIRATORY DISORDER 1 0.0000
16 NEOPLASM PROGRESSION 1 0.0000
17 RESTLESSNESS 1 0.0000
18 NEUTROPHIL COUNT DECREASED 1 0.0000
19 TREATMENT FAILURE 2 0.0000
20 WITHDRAWAL SYNDROME 1 0.0000
21 HYPOKALAEMIA 1 0.0000
22 OEDEMA 1 0.0000
23 TOXICITY TO VARIOUS AGENTS 3 0.0000
24 PRODUCT SUBSTITUTION ISSUE 1 0.0000
25 INTENTIONAL OVERDOSE 1 0.0000
26 DEHYDRATION 2 0.0000
27 NEOPLASM MALIGNANT 1 0.0000
28 AGITATION 1 0.0000
29 GASTROINTESTINAL DISORDER 1 0.0000
30 DEVICE ISSUE 1 0.0000
31 SUICIDAL IDEATION 1 0.0000
32 ADVERSE EVENT 1 0.0000
33 DYSPEPSIA 1 0.0000
34 SOMNOLENCE 2 0.0000
35 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
36 ILLNESS 1 0.0000
37 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
38 CONSTIPATION 2 0.0000
39 SEPSIS 1 0.0000
40 THROMBOCYTOPENIA 1 0.0000
41 INJECTION SITE ERYTHEMA 1 0.0000
42 PRODUCT QUALITY ISSUE 1 0.0000
43 VISION BLURRED 1 0.0000
44 URTICARIA 1 0.0000
45 MUSCLE SPASMS 1 0.0000
46 NASOPHARYNGITIS 1 0.0000
47 ASTHENIA 2 0.0000
48 GAIT DISTURBANCE 1 0.0000
49 ERYTHEMA 1 0.0000
50 DEATH 4 0.0000
51 WEIGHT INCREASED 1 0.0000
52 NAUSEA 3 0.0000
53 INSOMNIA 1 0.0000
54 COUGH 1 0.0000
55 CONDITION AGGRAVATED 1 0.0000
56 PNEUMONIA 1 0.0000
57 PYREXIA 1 0.0000
58 PRURITUS 1 0.0000
59 RASH 1 0.0000
60 OFF LABEL USE 2 0.0000
61 MALAISE 1 0.0000
62 VOMITING 1 0.0000
63 DIZZINESS 1 0.0000
64 PAIN 1 0.0000
65 DIARRHOEA 1 0.0000